US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Med-X, Inc.
Med-X President Jennifer Mills Launches New “Mills on the Mic” Podcast
July 13, 2022
From
Med-X, Inc.
Via
AccessWire
Med-X Announces Participation in Upcoming Industry Conferences
July 06, 2022
From
Med-X, Inc.
Via
AccessWire
Med-X Secures Nature-Cide Distribution Partnership with Oldham Chemicals Co.
June 27, 2022
From
Med-X, Inc.
Via
AccessWire
Topics
Supply Chain
Med-X Launches Internal Environmental, Social, and Governance (ESG) Preliminary Reporting Initiative
March 29, 2022
From
Med-X, Inc.
Via
AccessWire
Med-X Appoints Respected Pest Control Professional Gregory Pettis as Vice President of Business Development of its Nature-Cide Division
January 25, 2022
From
Med-X, Inc.
Via
AccessWire
Med-X Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
January 18, 2022
From
Med-X, Inc.
Via
AccessWire
